Literature DB >> 20184940

Molecular features of thyroid oncocytic tumors.

Giuseppe Gasparre1, Elena Bonora, Giovanni Tallini, Giovanni Romeo.   

Abstract

Thyroid oncocytic neoplasms are tumors composed of cells characterized by an aberrant increase of mitochondrial mass. They represent a subset of thyroid tumors whose classification and clinical features has been a matter of controversy for clinicians and pathologists alike. The prevalence of oncocytic tumors in the thyroid gland, the relevance of the issues debated, and the obvious cellular derangement of oncocytic cells, namely a complete deregulation of the mitochondrial mass and metabolism, have spurred many investigators to study the molecular mechanism underlying the genesis of this peculiar cancer phenotype. Their findings, which are unraveling the tumor pathobiology, are the subject of the present review. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20184940     DOI: 10.1016/j.mce.2010.02.022

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  13 in total

1.  High-resolution genomic profiling of thyroid lesions uncovers preferential copy number gains affecting mitochondrial biogenesis loci in the oncocytic variants.

Authors:  Ivana Kurelac; Dario de Biase; Claudia Calabrese; Claudio Ceccarelli; Charlotte Ky Ng; Raymond Lim; Alan MacKay; Britta Weigelt; Anna Maria Porcelli; Jorge S Reis-Filho; Giovanni Tallini; Giuseppe Gasparre
Journal:  Am J Cancer Res       Date:  2015-05-15       Impact factor: 6.166

2.  Outcome and molecular characteristics of non-invasive encapsulated follicular variant of papillary thyroid carcinoma with oncocytic features.

Authors:  Bin Xu; Ed Reznik; R Michael Tuttle; Jeffrey Knauf; James A Fagin; Nora Katabi; Snjezana Dogan; Nathaniel Aleynick; Venkatraman Seshan; Sumit Middha; Danny Enepekides; Gian Piero Casadei; Erica Solaroli; Giovanni Tallini; Ronald Ghossein; Ian Ganly
Journal:  Endocrine       Date:  2019-01-28       Impact factor: 3.633

3.  Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma.

Authors:  Raj K Gopal; Kirsten Kübler; Sarah E Calvo; Paz Polak; Dimitri Livitz; Daniel Rosebrock; Peter M Sadow; Braidie Campbell; Samuel E Donovan; Salma Amin; Benjamin J Gigliotti; Zenon Grabarek; Julian M Hess; Chip Stewart; Lior Z Braunstein; Peter F Arndt; Scott Mordecai; Angela R Shih; Frances Chaves; Tiannan Zhan; Carrie C Lubitz; Jiwoong Kim; A John Iafrate; Lori Wirth; Sareh Parangi; Ignaty Leshchiner; Gilbert H Daniels; Vamsi K Mootha; Dora Dias-Santagata; Gad Getz; David G McFadden
Journal:  Cancer Cell       Date:  2018-08-13       Impact factor: 31.743

4.  Oncocytic adrenocortical tumor with uncertain malignant potential in pediatric population: A case report and review of literature.

Authors:  Xiao-Chun Chen; Yun-Man Tang; Yu Mao; Dao-Rui Qin
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

Review 5.  Somatic mitochondrial DNA mutations in cancer escape purifying selection and high pathogenicity mutations lead to the oncocytic phenotype: pathogenicity analysis of reported somatic mtDNA mutations in tumors.

Authors:  Luísa Pereira; Pedro Soares; Valdemar Máximo; David C Samuels
Journal:  BMC Cancer       Date:  2012-02-02       Impact factor: 4.430

6.  Genome haploidisation with chromosome 7 retention in oncocytic follicular thyroid carcinoma.

Authors:  Willem E Corver; Dina Ruano; Karin Weijers; Wietske C E den Hartog; Merlijn P van Nieuwenhuizen; Noel de Miranda; Ronald van Eijk; Anneke Middeldorp; Ekaterina S Jordanova; Jan Oosting; Ellen Kapiteijn; Guido Hovens; Jan Smit; Tom van Wezel; Hans Morreau
Journal:  PLoS One       Date:  2012-06-01       Impact factor: 3.240

Review 7.  American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment.

Authors:  David C Shonka; Alan Ho; Ashish V Chintakuntlawar; Jessica L Geiger; Jong C Park; Nagashree Seetharamu; Sina Jasim; Amr H Abdelhamid Ahmed; Keith C Bible; Marcia S Brose; Maria E Cabanillas; Kirsten Dabekaussen; Louise Davies; Dora Dias-Santagata; James A Fagin; William C Faquin; Ronald A Ghossein; Raj K Gopal; Akira Miyauchi; Yuri E Nikiforov; Matthew D Ringel; Bruce Robinson; Mabel M Ryder; Eric J Sherman; Peter M Sadow; Jennifer J Shin; Brendan C Stack; R Michael Tuttle; Lori J Wirth; Mark E Zafereo; Gregory W Randolph
Journal:  Head Neck       Date:  2022-03-11       Impact factor: 3.821

8.  A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors.

Authors:  Cecilia Evangelisti; Dario de Biase; Ivana Kurelac; Claudio Ceccarelli; Holger Prokisch; Thomas Meitinger; Paola Caria; Roberta Vanni; Giovanni Romeo; Giovanni Tallini; Giuseppe Gasparre; Elena Bonora
Journal:  BMC Cancer       Date:  2015-03-21       Impact factor: 4.430

9.  Analysis of loss of heterozygsity effect on thyroid tumor with oxyphilia cell locus in familial non medullary thyroid carcinoma in Iranian families.

Authors:  Hasti Atashi Shirazi; Mehdi Hedayati; Maryam Sadat Daneshpour; Abdollah Shafiee; Fereidoun Azizi
Journal:  Indian J Hum Genet       Date:  2012-09

10.  Gamma rays induce a p53-independent mitochondrial biogenesis that is counter-regulated by HIF1α.

Authors:  A Bartoletti-Stella; E Mariani; I Kurelac; A Maresca; M F Caratozzolo; L Iommarini; V Carelli; L H Eusebi; A Guido; G Cenacchi; L Fuccio; M Rugolo; A Tullo; A M Porcelli; G Gasparre
Journal:  Cell Death Dis       Date:  2013-06-13       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.